Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus

Published on 3 May 2024 on Zacks via Yahoo Finance

Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus

Kymera Therapeutics, Inc. KYMR reported a loss of 69 cents per share in the first quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 73 cents. In the year-ago quarter, Kymera reported a loss of 70 cents per share.

Collaboration revenues totaled $10.3 million, which missed the Zacks Consensus Estimate of $12 million. Revenues increased 8.7% from the year-ago quarter’s level.

Read the rest of the article

NASDAQ.KYMR price evolution

NASDAQ.ANIP price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect

ANI Pharmaceuticals Inc (NASDAQ:ANIP) is set to release its Q3 2024 earnings on Nov 8, 2024. The...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

ANI Pharmaceuticals, Inc. (ANIP): A Cheap Pharmaceutical Stock to Buy According...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Selle...

Insider Monkey · via Yahoo Finance 19 Aug 2024

ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) just released its quarterly report and things are looking...

Simply Wall St. via Yahoo Finance 16 May 2024

Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)

On May 14, 2024, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc (NASDAQ:ANIP), execut...

GuruFocus.com via Yahoo Finance 16 May 2024

Earnings call: ANI Pharmaceuticals announced a 29% increase in total revenues By Investing.com

ANI Pharmaceuticals (NASDAQ:ANIP), Inc. (ANI) has announced a significant 29% year-over-year...

Investing.com 10 May 2024

Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)

Investors are always looking for stocks that are poised to beat at earnings season and ANI Pharma...

Zacks via Yahoo Finance 10 May 2024

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Is Going Strong But Fundamentals Look Uncertain: What...

Most readers would already be aware that ANI Pharmaceuticals' (NASDAQ:ANIP) stock increased signi...

Simply Wall St. via Yahoo Finance 10 May 2024

Will Petrobras (PBR) Report Q1 Earnings Beat on Output Gains?

Petroleo Brasileiro S.A., or Petrobras PBR is set to release first-quarter 2024 results on May 13...

Zacks via Yahoo Finance 9 May 2024

CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

We expect investors to focus on the initial sales numbers of CRISPR Therapeutics AG’s CRSP newly ...

Zacks via Yahoo Finance 7 May 2024

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

ANI Pharmaceuticals ANIP is slated to report first-quarter 2024 results on May 10, before the ope...

Zacks via Yahoo Finance 7 May 2024

News

Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus

NASDAQ.KYMR price evolution

NASDAQ.ANIP price evolution

Want to become a better investor?